DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2021 年 03 月 15 日 9:00 上午 - 2021 年 03 月 19 日 4:30 下午

(Central Europe Standard Time)

4051 Basel, Switzerland

DIA EUROPE 2021

Advancing Nanomedicines Into the Clinics by Applying a Multidisciplinary Approach

Session Chair(s)

Mark   van Eldijk

Mark van Eldijk

Group leader

Ardena, Belgium

Nanomedines are used in a variety of ways, both for drug delivery purposes and as tools for medical applications such as imaging and tissue engineering. Especially the benefit of nanomedicines in drug delivery has been proven as they confer unique pharmacokinetic and therapeutic effects such as improved dissolution rate and oral bioavailability, targeted delivery, improved efficacy, and decreased toxicity. As the control of materials in the nanometer size range requires scientifically demanding chemistry, analysis and manufacturing techniques special capacities are required to enable the clinical development of nanomedicines as versatile units. Since clinical development requires different capacities, it is extremely important to have access to a linked, multidisciplinary technology portfolio. In this session we would like to share experiences about which competencies are required and how capacities can be optimally used to allow nanomedicines to advance in clinical development.

Speaker(s)

Mark   van Eldijk

Technology Deep Dive

Mark van Eldijk

Ardena, Belgium

Group leader

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。